Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Browse by Category

  Research Highlight from:
  2023 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |

2014 Research Highlight


Tools to identify the men with prostate cancer most appropriate for active surveillance?
Robert H Getzenberg
Asian J Androl : 97-98; 10.4103/1008-682X.122369
Abstract |Full TextPDF [2334]


More evidence intratumoral DHT synthesis drives castration-resistant prostate cancer
Elizabeth M. Wilson
Asian J Androl : 99-100; 10.4103/1008-682X.122200
Abstract |Full TextPDF [2196]


The multiple actions of testosterone in men: nature knows best
John W. Funder
Asian J Androl : 266-267; 10.4103/1008-682X.122367
Abstract |Full TextPDF [1948]| 中文摘要


Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo
Richard G. Pestell1, Zuoren Yu2
Asian J Androl : 268-269; 10.4103/1008-682X.122364
Abstract |Full TextPDF [1835]| 中文摘要


Next generation patient-derived prostate cancer: xenograft models
Dong Lin1,2, Hui Xue1,2, Yuwei Wang1,2, Rebecca Wu1,2, Akira Watahiki1,2, Xin Dong2, Hongwei Cheng2, Alexander W. Wyatt1, Colin C. Collins1,3, Peter W. Gout2 and Yuzhuo Wang1,2,3
Asian J Androl : 407-412; 10.4103/1008-682X.125394
Full TextPDF [1892]


Long-term survival of participants in the prostate cancer: prevention trial
Jonathan L Silberstein1, Oliver Sartor1,2
Asian J Androl : 413-414; 10.4103/1008-682X.122868
Full TextPDF [1821]


Morbidity and psychological impact of prostate biopsy: the future calls for a change
Andrea Minervini, Gianni Vittori, Giampaolo Siena, Marco Carini
Asian J Androl : 415-417; 10.4103/1008-682X.126388
Full TextPDF [1816]


Long noncoding RNA-mediated activation of androgen receptor in prostate cancer
Gyorgy Petrovics, Shiv Srivastava
Asian J Androl : 418-419; 10.4103/1008-682X.126398
Full TextPDF [1809]


Trading in your spindles for blebs: the amoeboid tumor cell phenotype in prostate cancer
Samantha Morley1, Martin H Hager2, Sara G Pollan3, Beatrice Knudsen3, Dolores Di Vizio1, Michael R Freeman4
Asian J Androl : 530-535; 10.4103/1008-682X.122877
Abstract |Full TextPDF [1767]| 中文摘要


Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification
Yan Ting Chiang, Peter W Gout, Colin C Collins, Yuzhuo Wang
Asian J Androl : 545-548; 10.4103/1008-682X.122875
Abstract |Full TextPDF [1804]| 中文摘要


Androgen receptor functions in prostate cancer development and progression
Steven P Balk
Asian J Androl : 561-564; 10.4103/1008-682X.126396
Abstract |Full TextPDF [1806]| 中文摘要


Looking down on sperm motion: a useful added dimension?
Trevor G Cooper
Asian J Androl : 567-567; 10.4103/1008-682X.129135
Full TextPDF [1808]


Exploring the role of anti‑angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib
Himisha Beltran, Gurveen Kaur, Carmen Garcías de España, Scott T Tagawa
Asian J Androl : 568-569; 10.4103/1008-682X.127822
Full TextPDF [1799]


Management of localized prostate cancer: the pendulum swings (back to the middle)
Winston Vuong1, Oliver Sartor2, Sumanta K Pal1
Asian J Androl : 570-571; 10.4103/1008-682X.131072
Full TextPDF [1813]


Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation
John Lai1,2, Jyotsna Batra1,2
Asian J Androl : 659-660; doi: 10.4103/1008-682X.133323
Full TextPDF [1480]


Lipogenic metabolism: a viable target for prostate cancer treatment?
Mengmeng Liang, David J Mulholland
Asian J Androl : 661-663; 10.4103/1008-682X.132947
Full TextPDF [2379]


Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?
Luca Incrocci
Asian J Androl : 664-665; 10.4103/1008-682X.133324
Full TextPDF [2420]


Reappraisal of glucocorticoids in castrate-resistant prostate cancer
Oliver Sartor1, Christopher C Parker2, Johann de Bono2
Asian J Androl : 666-666; doi: 10.4103/1008-682X.133314
Full TextPDF [2418]


Which one is the real matchmaker for the pair?
Chunsheng Han
Asian J Androl : 667-668; 10.4103/1008-682X.133316
Full TextPDF [2399]


Regulation of cell adhesion in the testis: a new role for p73
Helen E. Abud1, Gary R. Hime2
Asian J Androl : 799-800; 10.4103/1008-682X.133315
Abstract |Full TextPDF [1427]


Unraveling the intricacies of mammalian fertilization
Satish K Gupta
Asian J Androl : 801-802; doi: 10.4103/1008-682X.133325
Abstract |Full TextPDF [1417]


Further analysis of PREVAIL: Enzalutamide use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer
Jeanny B Aragon-Ching
Asian J Androl : 803-804; 10.4103/1008-682X.135129
Abstract |Full TextPDF [1337]


Prevention of erectile dysfunction after radiotherapy for prostate cancer
Izak Faiena1, Neal Patel1, Allen D. Seftel2
Asian J Androl : 805-806; 10.4103/1008-682X.133327
Abstract |Full TextPDF [1380]


Enzalutamide in chemo-naïve CRPC: effective for most but not for all
Benjamin L Maughan, Emmanuel S Antonarakis
Asian J Androl : 807-808; 10.4103/1008-682X.137680
Abstract |Full TextPDF [1421]

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.